In a mouse tumor model, mitochondrial activation chemicals such as reactive oxygen species precursors or mitochondrial uncouplers synergized with PD-1 blocking immunotherapy, improving antitumor responses [75]. The gene discussed is PDCD1; the disease is neoplasm.